Skip to main content
PMC home page
Emergency Medicine Journal : EMJ logoLink to Emergency Medicine Journal : EMJ
. 2003 Jul;20(4):335–338. doi: 10.1136/emj.20.4.335

Acute bacterial gastroenteritis: a study of adult patients with positive stool cultures treated in the emergency department

S Chan 1, K Ng 1, D Lyon 1, W Cheung 1, A Cheng 1, T Rainer 1
PMCID: PMC1726145  PMID: 12835343

Abstract

Objectives: To investigate the presenting clinical features of acute bacterial gastroenteritis in adult patients treated as outpatients in the emergency department (ED), and the pathogens responsible in this setting and population; and to identify the frequency with which positive stool culture result changes management.

Method: This was a retrospective study of all patients who attended the accident and emergency department of an university affiliated hospital in Hong Kong over a 12 month period, who satisfied the following inclusion criteria: (a) age ⩾16, (b) presented with acute gastroenteritis, (c) treated as outpatients with or without observation, and (d) had positive stool cultures.

Results: One hundred and thirty patients were included. Pathogens identified were Vibrio parahaemolyticus (42.3%), Samonella spp (34.6%), Plesiomonas spp (9.2%), Campylobacter spp (6.9%), Aeromonas spp (6.9%), and Shigella spp (6.2%). Mean highest body temperature was 37.5°C (95% confidence intervals (CI) 37.3 to 37.6). Bloody diarrhoea was present in 14 patients (10.8%). Mean duration of diarrhoea, from onset to the completion of stay in ED, was 2.2 days (95% CI 1.7 to 2.7). Likewise, mean duration of abdominal pain was 1.8 days (95% CI 1.5 to 2.1). Mean number of unformed stools per day was 9.3 (95% CI 8.3 to 10.3). Change of management, subsequent to the availability of positive stool culture results, was not required in 115 (88.5%) patients. Ciprofloxacin resistance occurred in eight (6.2%) cases, and seven of nine campylobacter isolates. Campylobacter positive patients had a significantly longer duration of abdominal pain (p=0.0236) and were less likely to be dehydrated (p=0.0103).

Conclusions: Most patients with bacterial gastroenteritis do not present with high fever, bloody diarrhoea, or persistent diarrhoea, but generally have quite severe diarrhoea. Stool cultures do not change management for most patients. Vibrio parahaemolyticus is the commonest bacterial pathogen identified.

Full Text

The Full Text of this article is available as a PDF (102.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhan M. K., Raj P., Levine M. M., Kaper J. B., Bhandari N., Srivastava R., Kumar R., Sazawal S. Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India. J Infect Dis. 1989 Jun;159(6):1061–1064. doi: 10.1093/infdis/159.6.1061. [DOI] [PubMed] [Google Scholar]
  2. Biswas R., Lyon D. J., Nelson E. A., Lau D., Lewindon P. J. Aetiology of acute diarrhoea in hospitalized children in Hong Kong. Trop Med Int Health. 1996 Oct;1(5):679–683. doi: 10.1111/j.1365-3156.1996.tb00095.x. [DOI] [PubMed] [Google Scholar]
  3. Daniels N. A., Ray B., Easton A., Marano N., Kahn E., McShan A. L., 2nd, Del Rosario L., Baldwin T., Kingsley M. A., Puhr N. D. Emergence of a new Vibrio parahaemolyticus serotype in raw oysters: A prevention quandary. JAMA. 2000 Sep 27;284(12):1541–1545. doi: 10.1001/jama.284.12.1541. [DOI] [PubMed] [Google Scholar]
  4. Dryden M. S., Gabb R. J., Wright S. K. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis. 1996 Jun;22(6):1019–1025. doi: 10.1093/clinids/22.6.1019. [DOI] [PubMed] [Google Scholar]
  5. DuPont H. L. Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1997 Nov;92(11):1962–1975. [PubMed] [Google Scholar]
  6. DuPont H. L., Reves R. R., Galindo E., Sullivan P. S., Wood L. V., Mendiola J. G. Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. N Engl J Med. 1982 Sep 30;307(14):841–844. doi: 10.1056/NEJM198209303071401. [DOI] [PubMed] [Google Scholar]
  7. Ericsson C. D., Johnson P. C., Dupont H. L., Morgan D. R., Bitsura J. A., de la Cabada F. J. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial. Ann Intern Med. 1987 Feb;106(2):216–220. doi: 10.7326/0003-4819-106-2-216. [DOI] [PubMed] [Google Scholar]
  8. George W. L., Nakata M. M., Thompson J., White M. L. Aeromonas-related diarrhea in adults. Arch Intern Med. 1985 Dec;145(12):2207–2211. [PubMed] [Google Scholar]
  9. Goodman L. J., Trenholme G. M., Kaplan R. L., Segreti J., Hines D., Petrak R., Nelson J. A., Mayer K. W., Landau W., Parkhurst G. W. Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med. 1990 Mar;150(3):541–546. [PubMed] [Google Scholar]
  10. Guerrant R. L., Van Gilder T., Steiner T. S., Thielman N. M., Slutsker L., Tauxe R. V., Hennessy T., Griffin P. M., DuPont H., Sack R. B. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001 Jan 30;32(3):331–351. doi: 10.1086/318514. [DOI] [PubMed] [Google Scholar]
  11. Kaminski N., Bogomolski V., Stalnikowicz R. Acute bacterial diarrhoea in the emergency room: therapeutic implications of stool culture results. J Accid Emerg Med. 1994 Sep;11(3):168–171. doi: 10.1136/emj.11.3.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Marano N. N., Daniels N. A., Easton A. N., McShan A., Ray B., Wells J. G., Griffin P. M., Angulo F. J. A survey of stool culturing practices for vibrio species at clinical laboratories in Gulf Coast states. J Clin Microbiol. 2000 Jun;38(6):2267–2270. doi: 10.1128/jcm.38.6.2267-2270.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Park S. I., Giannella R. A. Approach to the adult patient with acute diarrhea. Gastroenterol Clin North Am. 1993 Sep;22(3):483–497. [PubMed] [Google Scholar]
  14. Piddock L. J. Quinolone resistance and Campylobacter spp. J Antimicrob Chemother. 1995 Dec;36(6):891–898. doi: 10.1093/jac/36.6.891. [DOI] [PubMed] [Google Scholar]
  15. Segreti J., Gootz T. D., Goodman L. J., Parkhurst G. W., Quinn J. P., Martin B. A., Trenholme G. M. High-level quinolone resistance in clinical isolates of Campylobacter jejuni. J Infect Dis. 1992 Apr;165(4):667–670. doi: 10.1093/infdis/165.4.667. [DOI] [PubMed] [Google Scholar]
  16. Smith K. E., Besser J. M., Hedberg C. W., Leano F. T., Bender J. B., Wicklund J. H., Johnson B. P., Moore K. A., Osterholm M. T. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. N Engl J Med. 1999 May 20;340(20):1525–1532. doi: 10.1056/NEJM199905203402001. [DOI] [PubMed] [Google Scholar]

Articles from Emergency Medicine Journal : EMJ are provided here courtesy of BMJ Publishing Group

RESOURCES